iShares US Pharmaceuticals ETF
IHE
IHE
99 hedge funds and large institutions have $91M invested in iShares US Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 95 → 99 (+4)
Holders
99
Holding in Top 10
–
Calls
$592K
Puts
–
Top Buyers
| 1 | +$6.23M | |
| 2 | +$2.03M | |
| 3 | +$1.3M | |
| 4 |
LPL Financial
San Diego,
California
|
+$1.04M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.02M |
Top Sellers
| 1 | -$6.81M | |
| 2 | -$3.73M | |
| 3 | -$568K | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$294K |
| 5 |
FWCM
Ferguson Wellman Capital Management
Portland,
Oregon
|
-$240K |